Nov 07, 2017 13:20 pm UTC| Business
Hamilton, Bermuda, November 7, 2017. Nordic American Tankers Limited (the "Company") (NYSE: NAT) today announced that its Board of Directors (the "Board") has scheduled the Company's 2017 Annual General Meeting of...
Nov 07, 2017 13:20 pm UTC| Business
Hamilton, Bermuda, November 7, 2017 Nordic American Offshore Ltd. (the "Company") (NYSE: NAO) today announced that its Board of Directors (the "Board") has scheduled the Company's 2017 Annual General Meeting of...
Snipp Expands Reporting and Analytics Capabilities
Nov 07, 2017 13:20 pm UTC| Business
TORONTO, Nov. 07, 2017 -- Snipp Interactive Inc. ("Snipp" or the “Company”) (OTCQB:SNIPF) (TSX-V:SPN), a global provider of digital marketing promotions, rebates and loyalty solutions, is pleased to announce that it has...
Nov 07, 2017 13:20 pm UTC| Business
NEW YORK, Nov. 07, 2017 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Take-Two...
Nov 07, 2017 13:19 pm UTC| Business
IRVINE, Calif., Nov. 07, 2017 -- Biomerica Inc. (NASDAQ:BMRA) today announced that it has extended its exclusive license agreement with Celtis Pharm Co. Ltd of South Korea. Celtis has changed its name to Telcon...
Nov 07, 2017 13:17 pm UTC| Business
KEEGO HARBOR, Mich., Nov. 07, 2017 -- ZIVO Bioscience, Inc., (OTCQB:ZIVO) a Michigan-based biotech firm, invites shareholders, analysts and partners to its annual shareholder meeting on Wednesday, November 8, 2017,...
Galectin Therapeutics Reports 2017 Third Quarter Financial Results and Provides Business Update
Nov 07, 2017 13:15 pm UTC| Business
All 52 weeks of infusions and 100% of the doses have been administered in the NASH Cirrhosis, NASH-CX Phase 2b Clinical Trial Top Line Results of NASH-CX Phase 2b Clinical Trial Expected to be announced in early December...
UK Inflation Stabilizes: November CPI at 2.6%, Signaling Economic Recovery
FDA Approval of Opdivo Injection Sparks Hope for Cancer Patients with Revolutionary Treatment Update